A federal grand jury in Dayton, Ohio, has indicted six Chinese nationals and two Chinese pharmaceutical companies on drug manufacturing and money laundering charges tied to the fentanyl supply chain that runs from Chinese labs through Mexican cartels and onto American streets.
The Department of Justice announced the charges on Wednesday, detailing a conspiracy to manufacture, possess, and distribute 400 grams or more of a fentanyl mixture, a drug prosecutors noted is up to 200 times as powerful as morphine. Every defendant, all eight, faces money laundering conspiracy charges as well.
The fentanyl charge alone carries a mandatory minimum sentence of 10 years and up to life in prison.
According to Newsmax, the individuals named in the indictment are Hanson Zhao, Gao Yanpeng, Xia Yi, Zhang Jian, Wang Zhaolan, and Zhang Chunhai. The two companies, Shandong Believe Chemical Company PTE Ltd. and Shandong Ranhang Biotechnology Co. Ltd., are also charged.
Three of the defendants go beyond ordinary drug charges. Zhao and the two Shandong companies are charged with attempting to provide material support to a designated foreign terrorist organization: Cartel del Golfo, the Gulf Cartel. That designation became possible after Secretary of State Marco Rubio classified a Mexican drug cartel as a foreign terrorist organization in February 2025, a move that unlocked an entirely new category of federal prosecution against the supply networks feeding cartel operations.
Zhao separately faces an obstruction of justice charge. The material support, money laundering, and obstruction counts each carry up to 20 years in prison.
The indictment alleges the companies converted funds into foreign currency overseas, a laundering mechanism designed to obscure the financial trail connecting Chinese chemical suppliers to cartel distribution networks inside the United States. This is the architecture of the fentanyl crisis laid bare: Chinese firms synthesize the precursors and cutting agents, cartels handle logistics and distribution, and American communities absorb the body count.
U.S. Attorney Dominick Gerace II framed the prosecution as part of a broader offensive. In a news release, he said:
"We are going after the entire chain of supply for these deadly drugs, from Mexican cartels and Chinese pharmaceutical companies to the high-level distributors on our streets in the Southern District of Ohio."
That language matters. "The entire chain of supply" signals a prosecution strategy that refuses to treat fentanyl deaths as a domestic policing problem alone. For years, enforcement focused on street-level dealers and users while the foreign manufacturers who feed the pipeline operated with near impunity. That approach failed. This one targets the source.
This is not the first time a Dayton grand jury has delivered this kind of indictment. In September, a separate federal grand jury in Dayton charged:
Those charges involved similar drug and money laundering conspiracies tied to illegal cutting agents. The scale is worth pausing on. In two rounds of indictments from a single federal district in Ohio, prosecutors have now named 28 Chinese nationals, six Chinese pharmaceutical companies, and three American citizens in fentanyl-related conspiracies.
Ohio is not a border state. It is not a port of entry. It is the kind of place politicians used to call "the heartland" when they wanted to sound concerned and do nothing. What Dayton's grand juries keep revealing is that the fentanyl supply chain doesn't respect geography. It terminates wherever there are Americans to kill.
The material support charges against Zhao and the two Shandong companies represent something genuinely new in fentanyl enforcement. Before the foreign terrorist organization designation, prosecutors had drug statutes and money laundering statutes: powerful tools, but tools designed for criminal enterprises. The terrorist designation reframes the relationship between Chinese chemical suppliers and Mexican cartels as what it functionally is: logistical support for an organization waging war on American soil.
That reframing carries legal consequences. Material support charges bring federal counterterrorism resources, intelligence-sharing authorities, and asset-seizure mechanisms that drug statutes alone do not. It transforms fentanyl from a law enforcement problem into a national security priority, which is exactly what it has been for years while Washington pretended otherwise.
Tens of thousands of Americans die from fentanyl every year. The chemicals originate in China. The distribution runs through cartels. The profits flow back overseas. Every node in that chain now faces federal indictment in an Ohio courtroom.
The supply chain has names. Now it has charges to match.